Safety in Immunomodulatory Functions of Campath-1H (PC01)
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://immport.org/shared/study/SDY134
下载链接
链接失效反馈官方服务：
资源简介：
This is a multicenter, open label, single arm trial to evaluate the safety of alemtuzumab after kidney transplantation as part of a multitherapy regimen to prevent kidney graft loss and death and to avoid steroids and chronic use of calcineurin inhibitors in pediatric renal transplant recipients 1 to 20 years of age.
创建时间：
2025-10-30
